4/07/2022 9:43:00 AM | Source: Accord Fintech
Shilpa Medicare executes transfer agreement with Shilpa Pharma Lifesciences
Shilpa Medicare has executed business transfer agreement with Shilpa Pharma Lifesciences (Formerly known as Shilpa Corporate Holdings) the transferee company which is complete and effective from June 30, 2022. With effect from closing of the transaction, Shilpa Pharma Lifesciences, a wholly owned subsidiary of Shilpa Medicare shall operate the API (Active Pharmaceutical Ingredient) business.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
India safeguards agriculture sector, boosts farmer i...
Factbox-Highlights of U.S.-India interim trade frame...
US and India unveil interim trade framework, move cl...
Great news: PM Narendra Modi hails India, US interim...
National seminar on pulses in Madhya Pradesh today t...
Interim US trade pact to open?$30 trillion market fo...
India`s forex reserves surge by $14.36 billion to re...
Evening Roundup : Daily Evening Report on Bullion, B...
South Gujarat export sectors to gain from India-EU f...
US delegation seeks collaboration with India across ...
Tag News
News Not Found
